Wilmington Savings Fund Society FSB Cuts Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Wilmington Savings Fund Society FSB decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,563 shares of the company’s stock after selling 715 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in GE HealthCare Technologies were worth $826,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. State Street Corp increased its position in shares of GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after acquiring an additional 1,347,114 shares during the period. Geode Capital Management LLC raised its position in GE HealthCare Technologies by 7.2% in the 3rd quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock valued at $1,026,898,000 after purchasing an additional 733,819 shares in the last quarter. D1 Capital Partners L.P. purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $268,159,000. Charles Schwab Investment Management Inc. grew its position in shares of GE HealthCare Technologies by 12.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock worth $254,422,000 after buying an additional 290,019 shares in the last quarter. Finally, Van ECK Associates Corp acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $208,513,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $87.50 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.55. The stock’s 50-day moving average price is $83.43 and its 200 day moving average price is $85.34. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $39.98 billion, a PE ratio of 24.04, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.